ENTITY

Sihuan Pharmaceutical Hldgs (460 HK)

50

Analysis

Health Care • China

Sihuan Pharmaceutical Holdings Group Ltd. researches and develops cardiocerebral vascular drugs in China. The Company drugs address needs in the areas of anti-infective, metabolism, cardiovascular system, oncology and nervous system.

more

Refresh

Exchange Announcement • 21 Nov 2024 12:28

Voluntary Announcement-Huisheng Biopharmaceutical And Meiyan Space Reached An Exclusive Authorization Cooperation On Semaglutide Injection For Weight Loss

Exchange Announcement • 12 Nov 2024 22:07

(1) Voluntary Announcement-Proposed Spin-Off Of Xuanzhu Biopharm And Listing On The Main Board Of The Stock Exchange And (2) Discloseable Transaction-Further Acquisition Of Approximately 3.6177% Equity Interests In Xuanzhu Biopharm

Exchange Announcement • 06 Oct 2024 18:06

Voluntary Announcement Intention To Conduct Further On-Market Share Repurchase

Exchange Announcement • 27 Sep 2024 12:25

Voluntary Announcement-Exclusive Distribution Agreement For Botunlinum Toxin Letybo Renewed Until End Of The Year 2030

Exchange Announcement • 23 Sep 2024 16:36

Notification Letter And Request Form To Non-Registered Holder

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5

x